• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Elliot A. Asare, MD, MS, CMQ, FACS

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
23 4.9 out of 5 Patient Rating

Languages Spoken: English

Elliot Asare, MD, MS is an Assistant Professor in the Section of Surgical Oncology within the Division of General Surgery at the University of Utah. Dr. Asare specializes in cutaneous malignancies and sarcomas of the retroperitoneum and other soft tissues.

Dr. Asare is a Phi Beta Kappa graduate of Randolph-Macon College in Ashland, Virginia where he was a double major in Chemistry and Biology. He subsequently received his medical education at Howard University College of Medicine, Washington, DC and was inducted into the Alpha Omega Alpha Medical Honors Society. He had his General Surgery residency training at the Medical College of Wisconsin Affiliated Hospitals in Milwaukee, WI. Dr. Asare served as a clinical scholar-in-residence with the American Joint Committee on Cancer (AJCC) during residency. He has a masters degree in health services and outcomes research from Northwestern University, Chicago, IL. Following residency, he trained in Complex General Surgical Oncology at the University of Texas MD Anderson Cancer Center, Houston, TX.

Dr. Asare’s research interests include improving cancer data quality, cancer staging, prognostication, surveillance, clinical trials and outcomes research. He practices both at the Huntsman Cancer Institute and Intermountain Healthcare Center in Murray.

Clinical Locations

Huntsman Cancer Hospital

801-587-8808

Fax: (801) 581-6470

1950 Circle of Hope
Salt Lake City, UT  84112
Map

Specialties

  • Oncology Surgery
  • Sarcomas
  • Melanoma and Cutaneous Oncology
  • Soft Tissue Sarcoma Surgery
  • Gastrointestinal Stromal Tumors
  • High Risk Skin Cancer

Board Certification and Academic Information

Academic Departments Surgery - Assistant Professor (Clinical)
Academic Divisions General Surgery
Board Certification American Board of Medical Quality
American Board of Surgery (Sub: Complex General Surgical Oncology)
American Board of Surgery (Sub: General Surgery)

Patient Rating

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Learn About Our Survey

Likelihood of recommending care provider

4.9/ 5

Care provider's explanation of condition/problem

4.8/ 5

Care provider's effort to include me in decisions

4.9/ 5

Wait time at clinic

4.7/ 5

Care provider's concern for questions & worries

4.9/ 5

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

UofU Patient October 25, 2022
Huntsman Cancer Institute

5 out of 5 stars

Jacob and Dr Asare were polite knowledgeable respectful and very kind !

UofU Patient September 19, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr Asare gave me great detail on my options.

UofU Patient August 09, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr.Asare is a very caring person.He is thorough in his explanation

UofU Patient July 03, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

I cannot say enough good things!

UofU Patient May 25, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

I cannot say enough good things!!

UofU Patient May 22, 2022
HUNTSMAN CANCER CENTER

3 out of 5 stars

I felt like I was being sold a product.

UofU Patient May 22, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Great experience

UofU Patient May 17, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr Asare is the most professional and compassionate surgeon.

UofU Patient May 10, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

At one point my husband was feeling overwhelmed and dizzy. The doctor immediately ordered water and helped him to a chair. Very kind and caring professionalsDr Asare spoke to my husband not at him and went through all the lab results and go forward treatment planHis kindness to listen and patiently explain his current medical condition put my husband more at ease and a feeling of being in control or collaborative with appropriate decision making

UofU Patient March 07, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

I had some questions about my surgery & aftercare and Dr Asare set up virtual appt to address concerns. I was appreciative that he could meet with me to address.

UofU Patient February 13, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Good

UofU Patient November 23, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr Asari is very good

UofU Patient November 21, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

My options were explained along with the pros and cons.

UofU Patient August 18, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Everything about the experience there has been exceptional!

UofU Patient July 28, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Asare was wonderfully extraordinary!!!

UofU Patient July 11, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Most outstanding physician that I have been privileged to know. Communicated very well his concern for my well-being.

UofU Patient June 20, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Asare was great. I was very impressed with him.

UofU Patient June 13, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

I felt very comfortable and confident with my experience with Dr. Asare

UofU Patient May 10, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Asare fully described the proposed procedure - answering all questions an explaining the follow-up steps. I felt quite comfortable that the process would go well.

UofU Patient April 19, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

the only thing was that it was described to me that the melanoma removal would be 1cm around it but my scar is much much bigger than that so I was a little taken aback when I took my dressing off. it would have been nice to be warned that the scar itself would be massive in comparison but of course - SO glad it's all out!

UofU Patient March 29, 2021
HUNTSMAN CANCER CENTER

4 out of 5 stars

Direct and nice.

UofU Patient March 15, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Very informative

UofU Patient February 07, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

good

Elliot Asare, MD, MS is an Assistant Professor in the Section of Surgical Oncology within the Division of General Surgery at the University of Utah. Dr. Asare specializes in cutaneous malignancies and sarcomas of the retroperitoneum and other soft tissues.

Dr. Asare is a Phi Beta Kappa graduate of Randolph-Macon College in Ashland, Virginia where he was a double major in Chemistry and Biology. He subsequently received his medical education at Howard University College of Medicine, Washington, DC and was inducted into the Alpha Omega Alpha Medical Honors Society. He had his General Surgery residency training at the Medical College of Wisconsin Affiliated Hospitals in Milwaukee, WI. Dr. Asare served as a clinical scholar-in-residence with the American Joint Committee on Cancer (AJCC) during residency. He has a masters degree in health services and outcomes research from Northwestern University, Chicago, IL. Following residency, he trained in Complex General Surgical Oncology at the University of Texas MD Anderson Cancer Center, Houston, TX.

Dr. Asare’s research interests include improving cancer data quality, cancer staging, prognostication, surveillance, clinical trials and outcomes research. He practices both at the Huntsman Cancer Institute and Intermountain Healthcare Center in Murray.

Academic Locations

Board Certification and Academic Information

Academic Departments Surgery - Assistant Professor (Clinical)
Academic Divisions General Surgery
Board Certification American Board of Medical Quality
American Board of Surgery (Sub: Complex General Surgical Oncology)
American Board of Surgery (Sub: General Surgery)

Education History

Fellowship University of Texas MD Anderson Cancer Center
Complex General Surgical Oncology
Clinical Fellow, 2019
Residency Medical College of Wisconsin Affiliated Hospitals
General Surgery
Resident, 2017
Graduate Training Northwestern University Feinberg School of Medicine
Health Services and Outcomes Research
M.S., 2015
Residency Medical College of Wisconsin Affiliated Hospitals
General Surgery
Resident, 2013
Internship Medical College of Wisconsin Affiliated Hospitals
General Surgery
Intern, 2011
Doctoral Training Howard University College of Medicine
Medicine
M.D., 2010
Undergraduate Randolph-Macon College
Biology and Chemistry (double major)
B.S., 2006

Selected Publications - Journal Articles

Journal Article

  1. Lillemoe HA, Williams JK, Teshome MK, Zheng L, Francescatti AB, Hieken TJ, Katz MH, Hunt KH, Vreeland TJ, Asare EA (2022). Setting the Standard for Cutaneous Melanoma Wide Local Excision: An Overview of the American College of Surgeons Commission on Cancer Standard 5.5. J Am Coll Surg, 236(2), 424-428.
  2. Pearson J, Jacobson C, Ugochukwu N, Asare E, Kan K, Pace N, Han J, Wan N, Schonberger R, Andreae M (2022). Geospatial analysis of patients' social determinants of health for health systems science and disparity research. Int Anesthesiol Clin, 61(1), 49-62.
  3. Elliot A Asare MD MS, Alisha Lussiez MD, Melissa H Watt, PhD, Charles K Dally, MD, Eileen A Micah, MBChB, Gifty Kwakye MD MPH (2022). Do you want to be told if you have cancer? A Cross-sectional Survey of Ghanaians . J Glob Health Rep, 6.
  4. Asare EA, Swami U, Stewart JH 4th (2021). Landmark Series on Disparities in Surgical Oncology: Melanoma. Ann Surg Oncol, 28, 6986-6993.
  5. Asare EA, Stewart JH 4th (2021). ASO Author Reflections: Melanoma Killed Bob Marley and Others Too. Ann Surg Oncol, 28, 6994.
  6. Bleicher J, Asare EA, Flores S, Bowles TL, Bowen GM, Hyngstrom JR (2020). Oncologic outcomes of patients with Merkel Cell Carcinoma (MCC): A multi-institutional cohort study. Am J Surg, 221(4), 844-849.
  7. Bleicher J, Cohan JN, Huang LC, Peche W, Pickron TB, Scaife CL, Bowles TL, Hyngstrom JR, Asare EA (2020). Trends in the management of anorectal melanoma: A multi-institutional retrospective study and review of the world literature. World J Gastroenterol, 27(3), 267-280.
  8. Bleicher J, Swords DS, Mali ME, McGuire L, Pahlkotter MK, Asare EA, Bowles TL, Hyngstrom JR (2020). Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance. J Surg Oncol, 122(8), 1770-1777.
  9. Keung EZ, Asare EA, Chiang YJ, Prakash LR, Rajkot N, Torres KE, Hunt KK, Feig BW, Cormier JN, Roland CL, Katz MHG, Lee JE, Tzeng CD (2019). Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg, 220(1), 140-146.
  10. Asare EA, Davis CH, Chiang YJ, Sabir S, Rajkot NF, Phillips PR, Roland CL, Torres KE, Hunt KK, Feig BW (2019). Management and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin. J Surg Oncol, 121(3), 474-479.
  11. Asare EA, Silva-Figueroa A, Hess KR, Busaidy N, Graham PH, Grubbs EG, Lee JE, Williams MD, Perrier ND (2019). Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center. Ann Surg Oncol, 26(11), 3593-3599.
  12. Asare EA, Perrier ND (2019). ASO Author Reflections: Distant Metastatic Parathyroid Carcinoma-Has the "Train Left the Station?". Ann Surg Oncol, 26(11), 3600-3601.
  13. Nobecourt PF, Zagzag J, Asare EA, Perrier ND (2018). Intraoperative Decision-Making and Technical Aspects of Parathyroidectomy in Young Patients With MEN1 Related Hyperparathyroidism. Front Endocrinol (Lausanne), 9, 618.
  14. Asare EA, Vreeland TJ, Feig BW (2018). Resection of a Perirectal Leiomyosarcoma via a Posterior Transcoccygeal Approach. Ann Surg Oncol, 25(9), 2641.
  15. Asare EA, Evans DB, Erickson BA, Aburajab M, Tolat P, Tsai S (2016). Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancer. J Surg Oncol, 114(3), 291-5.
  16. Asare EA, Liu L, Hess KR, Gordon EJ, Paruch JL, Palis B, Dahlke AR, McCabe R, Cohen ME, Winchester DP, Bilimoria KY (2015). Development of a model to predict breast cancer survival using data from the National Cancer Data Base. Surgery, 159(2), 495-502.
  17. Asare EA, Compton CC, Hanna NN, Kosinski LA, Washington MK, Kakar S, Weiser MR, Overman MJ (2015). The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base. Cancer, 122(2), 213-21.
  18. Asare EA, Sturgeon C, Winchester DJ, Liu L, Palis B, Perrier ND, Evans DB, Winchester DP, Wang TS (2015). Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). Ann Surg Oncol, 22(12), 3990-5.
  19. Asare EA, Greenberg S, Szabo S, Sato TT (2014). Giant Paratubal Cyst in Adolescence: Case Report, Modified Minimal Access Surgical Technique, and Literature Review. J Pediatr Adolesc Gynecol, 28(5), e143-5.
  20. Asare EA, Gress DM, Greene FL, Winchester DP (2015). Cancer registry data: Engaging the clinician to improve quality. Cancer, 121(17), 2866-7.
  21. Asare EA, Washington MK, Gress DM, Gershenwald JE, Greene FL (2015). Improving the quality of cancer staging. CA Cancer J Clin, 65(4), 261-3.
  22. Asare EA, Wang TS (2015). Comparative effectiveness in thyroid cancer: key questions and how to answer them. Cancer Treat Res, 164, 67-87.
  23. Asare EA, Wang TS, Winchester DP, Mallin K, Kebebew E, Sturgeon C (2014). A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease. Surgery, 156(6), 1378-85; discussion 1385-6.
  24. Kinnier CV, Asare EA, Mohanty S, Paruch JL, Rajaram R, Bilimoria KY (2014). Risk prediction tools in surgical oncology. J Surg Oncol, 110(5), 500-8.

Edited Book

  1. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (Eds.) (2017). AJCC Cancer Staging Manual. (8th Edition). Springer International Publishing.

Book Chapter

  1. Fisher SB, Asare EA, Habra MA, Perrier ND (2019). Chapter 16: Advances in the Diagnosis and Management of Adrenocortical Carcinoma. In Shifrin A (Ed.), Advances in Treatment and Management in Surgical Endocrinology. Elsevier.
  2. Asare EA, Evans DB, Tsai S (2019). Chapter 106. Unusual Pancreatic Tumors. In Cameron: Current Surgical Therapy (13). Elsevier.
  3. Asare EA, Wang H, Tamm EP, Mortenson MM, Evans DB, Tsai S (2019). Chapter 99: Unusual Pancreatic Tumors. In Yeo CJ, DeMeester SR, McFadden DW, Matthews JB, Fleshman JW (Eds.), Shackelford’s Surgery of the Alimentary Tract (8th Edition). Elsevier.
  4. Asare EA, Miura JT, Carr AA (2016). Adrenal Gland. In Surgery Review Illustrated (2nd edition). McGraw-Hill.
  5. Asare EA, Wang TS (2015). Comparative Effectiveness in Thyroid Cancer: Key Questions and How to Answer Them. In Bilimora KY, Minami CA, Mahvi DM (Eds.), Comparative Effectiveness in Surgical Oncology (164, pp. 67-87). Springer.

Editorial

  1. Asare EA, Andreae MH, Stewart JH 4th (2022). Bridging the Disparity Gap in Surgical Oncology Access: Does Telehealth Hold a Key? Ann Surg Oncol, 29, 7235-7236.
  2. Elliot A Asare, MD, MS, FACS (2021). NCDB-Generated Literature on Cancer Disparities.
  3. Asare EA, Grubbs EG, Gershenwald JE, Greene FL, Aloia TA (2019). Setting the "stage" for Surgical Oncology fellows: Pierre Denoix and TNM staging. J Surg Oncol, 119(7), 823.
  4. Asare EA, Feig BW (2019). Raining Frogs, Flying Horses, and Defining Tumor Rupture in GIST. Ann Surg Oncol, 26(6), 1601-1603.
  5. Asare EA, Bilimoria KY, Greene FL (2014). Beyond anatomic staging for cancer. J Surg Oncol, 111(3), 249-50.

Letter

  1. Elliot A Asare, MD, MS (2021). Public Perceptions: The Role of Residents in Operations [Letter to the editor].
  2. Asare EA, Perrier ND (2019). Letter to the Editor: "An Analysis of the American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma". [Letter to the editor]. J Clin Endocrinol Metab, 105(9).

Abstract

  1. Brunsgaard EK, Asare EA, Bowles TL, Hyngstrom JR (2022). Nodal surveillance and adjuvant therapy in sentinel lymph node-positive​ melanoma patients [Abstract].
  2. Davis C, Asare EA, Sabir SH, Roland CL, Torres KE, Hunt KK, Cormier JN, Feig BW (2018). Management and Outcomes of Patients with Fistulized Mesenchymal Tumors. Poster presented at the Society of Surgical Oncology 72nd Annual Cancer Symposium, San Diego, CA [Abstract]. 26, S179-80.
  3. Asare E, Vreeland T, Feig B (2018). Video abstract of a resection of a perirectal leiomyosarcoma via a posterior transcoccygeal approach with sphincter preservation. Society of Surgical Oncology 71st Annual Cancer Symposium, Chicago, IL [Abstract]. 25, S79-80.
  4. Keung E, Asare EA, Chiang YJ, Prakash L, Rajkot N, Roland CL, Torres KE, Cormier JN, Feig B, Katz MH, Lee JE, Tzeng CW (2018). Postoperative Pancreatic Fistula and Morbidity after Distal Pancreatectomy for Non-Pancreas Retroperitoneal Tumor Resection. Society of Surgical Oncology 72nd Annual Cancer Symposium, March 27-30, 2018, San Diego, CA, USA [Abstract]. Surgery (Oxf).
  5. Mizuno T, Goumard C, Okuno M, Asare EA, Krampitz GW, Aloia TA, Tzeng CWD, Chun YS, Lee JE, Vauthey JN, Nagino M, Conrad C (2018). Indocyanine green fluorescence counterstaining for anatomic laparoscopic partial splenectomy [Abstract]. 20, S41.
  6. Asare E, Compton C, Hanna N, Kakar S, Weiser M, Overman MJ (2015). The role of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National Cancer Database. Poster presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, San Francisco, CA [Abstract]. 33(3_suppl), 668.
  7. Asare E, Green D, Xiang Q, Gamblin TC, Turaga K, Pappas SG, Christians KK, Quebbeman EJ, Evans DB, Knechtges P, Tsai S (2012). Low lean body mass negatively predicts completion of neoadjuvant chemotherapy among patients with resectable and borderline resectable pancreatic cancer. Oral presentation at the 12th Annual Americas Hepato-Pancreato-Biliary Association (AHPBA) Meeting, Miami, FL [Abstract].
  8. Yalowich JC, Asare E, Giorgianni A (2006). Benzoquinone -induced inhibition of DNA topoisomerase II. [Abstract]. 1300-c-01.

Other

  1. Janet E Lindsley, PhD, Emine Ercikan Abali, PhD, Elliot A Asare, MD, MS, Marco Antonio Carvalho-Filho, MD, PhD, Candace Chow, PhD, MA, Marisol Hernandez, MLS, MA, Susan Jamieson, PhD, EdD, Amit Kaushal, MD, MScCH, Nicole N Woods, PhD (2021). Contribution of basic science to the professional identity development of medical learners: A BEME scoping review protocol. Best Evidence Medical and Health Professional Education.

Video/Film/CD/Web/Podcast

  1. Bowles TR, Asare EA (2021). Item writer for the TWIS Soft Tissue Neoplasm, Part 2 of 2 Quiz. The SCORE Portal.  [Web].
  2. Hyngstrom JR, Asare EA (2020). Hyngstrom JR, Asare EA. Item writer for the TWIS Soft Tissue Neoplasm, Part 1 of 2 Quiz. The SCORE Portal. http://www.surgicalcore.org. [Web].
  3. Asare EA, Gershenwald JE (2018). Melanoma – Wide Excision [Web]. The SCORE Portal.
  4. Asare EA (2015). Invited by Medscape Medical News to comment on how a new study on microscopic extension will affect the future of AJCC Cancer Staging for papillary thyroid cancer. Microscopic Extension Does Not Up PTC Recurrence or Death, by Miriam E. Tucker [Web]. Medscape Medical News.

Global Impact

Selected Provider Publications

Journal Article

  1. Elliot A Asare MD MS, Alisha Lussiez MD, Melissa H Watt, PhD, Charles K Dally, MD, Eileen A Micah, MBChB, Gifty Kwakye MD MPH (2022). Do you want to be told if you have cancer? A Cross-sectional Survey of Ghanaians . J Glob Health Rep, 6.
    Global Impact: Ghana.

Huntsman Cancer Institute News

Melanoma Research Innovations

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Price Estimate
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

Appointment Scheduling:
801-213-9500

Hospital Operator:
801-581-2121

En Español:
801-646-5914

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2023 University of Utah Health